• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷受体配体的功能选择性。

Functional selectivity of adenosine receptor ligands.

机构信息

Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, Leiden University, PO Box 9502, 2300 RA, Leiden, The Netherlands.

出版信息

Purinergic Signal. 2011 Jun;7(2):171-92. doi: 10.1007/s11302-011-9232-0. Epub 2011 May 5.

DOI:10.1007/s11302-011-9232-0
PMID:21544511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3146648/
Abstract

Adenosine receptors are plasma membrane proteins that transduce an extracellular signal into the interior of the cell. Basically every mammalian cell expresses at least one of the four adenosine receptor subtypes. Recent insight in signal transduction cascades teaches us that the current classification of receptor ligands into agonists, antagonists, and inverse agonists relies very much on the experimental setup that was used. Upon activation of the receptors by the ubiquitous endogenous ligand adenosine they engage classical G protein-mediated pathways, resulting in production of second messengers and activation of kinases. Besides this well-described G protein-mediated signaling pathway, adenosine receptors activate scaffold proteins such as β-arrestins. Using innovative and sensitive experimental tools, it has been possible to detect ligands that preferentially stimulate the β-arrestin pathway over the G protein-mediated signal transduction route, or vice versa. This phenomenon is referred to as functional selectivity or biased signaling and implies that an antagonist for one pathway may be a full agonist for the other signaling route. Functional selectivity makes it necessary to redefine the functional properties of currently used adenosine receptor ligands and opens possibilities for new and more selective ligands. This review focuses on the current knowledge of functionally selective adenosine receptor ligands and on G protein-independent signaling of adenosine receptors through scaffold proteins.

摘要

腺苷受体是一种位于细胞膜上的蛋白,能够将细胞外的信号转导至细胞内。基本上,每一种哺乳动物细胞都至少表达四种腺苷受体亚型中的一种。最近对信号转导级联的深入了解告诉我们,目前对受体配体的分类,包括激动剂、拮抗剂和反向激动剂,在很大程度上取决于所使用的实验设置。当这些受体被无处不在的内源性配体腺苷激活后,它们会与经典的 G 蛋白偶联途径结合,导致第二信使的产生和激酶的激活。除了这种描述明确的 G 蛋白介导的信号转导途径之外,腺苷受体还可以激活支架蛋白,如β-arrestin。利用创新和敏感的实验工具,已经有可能检测到那些优先刺激β-arrestin 途径而不是 G 蛋白介导的信号转导途径的配体,或者反之亦然。这种现象被称为功能选择性或偏向性信号传递,意味着一种途径的拮抗剂可能是另一种信号通路的完全激动剂。功能选择性使得有必要重新定义当前使用的腺苷受体配体的功能特性,并为新的和更具选择性的配体提供了可能性。本文综述了目前关于功能选择性腺苷受体配体的知识,以及通过支架蛋白进行的 G 蛋白非依赖性腺苷受体信号转导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/2cdd4855fb84/11302_2011_9232_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/804bd57913fd/11302_2011_9232_Fig1r1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/6f6567318062/11302_2011_9232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/d7852b75a486/11302_2011_9232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/d00faf5a5dee/11302_2011_9232_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/2cdd4855fb84/11302_2011_9232_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/804bd57913fd/11302_2011_9232_Fig1r1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/6f6567318062/11302_2011_9232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/d7852b75a486/11302_2011_9232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/d00faf5a5dee/11302_2011_9232_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ef/3146648/2cdd4855fb84/11302_2011_9232_Fig5_HTML.jpg

相似文献

1
Functional selectivity of adenosine receptor ligands.腺苷受体配体的功能选择性。
Purinergic Signal. 2011 Jun;7(2):171-92. doi: 10.1007/s11302-011-9232-0. Epub 2011 May 5.
2
Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.天然和合成前列腺素EP4受体配体的功能选择性
J Pharmacol Exp Ther. 2009 Oct;331(1):297-307. doi: 10.1124/jpet.109.156398. Epub 2009 Jul 7.
3
Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2.血清素5-HT1A受体的芳基哌嗪激动剂相对于β-抑制蛋白-2的募集更优先激活cAMP信号传导。
Bioorg Med Chem. 2015 Aug 1;23(15):4824-4830. doi: 10.1016/j.bmc.2015.05.042. Epub 2015 Jun 1.
4
Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.通过肾上腺素能α(2C)受体上G蛋白依赖性和非依赖性信号通路分析功能选择性
Brain Res Bull. 2014 Aug;107:89-101. doi: 10.1016/j.brainresbull.2014.07.005. Epub 2014 Jul 29.
5
Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling.代谢型谷氨酸受体 1a 上的配体偏向性:区分β-arrestin 介导和 G 蛋白介导信号转导的分子决定因素。
Mol Pharmacol. 2012 Aug;82(2):291-301. doi: 10.1124/mol.112.078444. Epub 2012 May 14.
6
Functional selectivity of adenosine A1 receptor ligands?腺苷 A1 受体配体的功能选择性?
Purinergic Signal. 2013 Mar;9(1):91-100. doi: 10.1007/s11302-012-9334-3. Epub 2012 Sep 28.
7
beta-arrestin-biased agonism at the beta2-adrenergic receptor.β2肾上腺素能受体上的β-抑制蛋白偏向性激动作用
J Biol Chem. 2008 Feb 29;283(9):5669-76. doi: 10.1074/jbc.M708118200. Epub 2007 Dec 17.
8
Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.甲状旁腺激素受体的偏激动作用:骨代谢中功能选择性的证明。
Mini Rev Med Chem. 2012 Aug;12(9):856-65. doi: 10.2174/138955712800959125.
9
Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.β-arrestin 偏向激动剂/拮抗剂在心血管七跨膜受体中的作用。
Curr Pharm Des. 2012;18(2):192-8. doi: 10.2174/138161212799040475.
10
β-arrestins and biased signaling in gonadotropin receptors.β-抑制蛋白与促性腺激素受体中的偏向性信号传导
Minerva Ginecol. 2018 Oct;70(5):525-538. doi: 10.23736/S0026-4784.18.04272-7. Epub 2018 Jul 10.

引用本文的文献

1
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?靶向腺苷受体的合成小分子配体:对缺血性心脏病有潜在作用吗?
Cells. 2025 Aug 7;14(15):1219. doi: 10.3390/cells14151219.
2
The flexibility of SABRE, a new quantitative receptor function model, when fitting challenging concentration-effect data.新型定量受体功能模型SABRE在拟合具有挑战性的浓度-效应数据时的灵活性。
Front Pharmacol. 2025 Jun 12;16:1591761. doi: 10.3389/fphar.2025.1591761. eCollection 2025.
3
Caffeine regulates both osteoclast and osteoblast differentiation via the AKT, NF-κB, and MAPK pathways.

本文引用的文献

1
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.国际基础和临床药理学联合会. LXXXI. 腺苷受体的命名和分类-更新。
Pharmacol Rev. 2011 Mar;63(1):1-34. doi: 10.1124/pr.110.003285. Epub 2011 Feb 8.
2
Recent developments in adenosine receptor ligands and their potential as novel drugs.腺苷受体配体的最新进展及其作为新型药物的潜力。
Biochim Biophys Acta. 2011 May;1808(5):1290-308. doi: 10.1016/j.bbamem.2010.12.017. Epub 2010 Dec 23.
3
Functional selectivity and biased receptor signaling.
咖啡因通过AKT、NF-κB和MAPK信号通路调节破骨细胞和成骨细胞的分化。
Front Pharmacol. 2024 Jun 13;15:1405173. doi: 10.3389/fphar.2024.1405173. eCollection 2024.
4
The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor.回归方式对受体反应性方法(RRM)所获结果的影响,RRM是一种用于估计受体附近药理激动剂浓度变化的方法。
Front Pharmacol. 2024 May 2;15:1375955. doi: 10.3389/fphar.2024.1375955. eCollection 2024.
5
Cryo-EM structures of adenosine receptor AAR bound to selective agonists.腺苷受体 AAR 与选择性激动剂结合的冷冻电镜结构。
Nat Commun. 2024 Apr 16;15(1):3252. doi: 10.1038/s41467-024-47207-6.
6
Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectives.A1 腺苷受体拮抗剂在心血管疾病治疗中的治疗效力、现状和展望。
Mol Biol Rep. 2024 Feb 24;51(1):358. doi: 10.1007/s11033-024-09246-6.
7
Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay.使用分裂荧光素酶检测法研究腺苷A1受体介导的β-抑制蛋白2募集
Front Pharmacol. 2023 May 30;14:1172551. doi: 10.3389/fphar.2023.1172551. eCollection 2023.
8
New paradigms in purinergic receptor ligand discovery.嘌呤能受体配体发现的新范式。
Neuropharmacology. 2023 Jun 1;230:109503. doi: 10.1016/j.neuropharm.2023.109503. Epub 2023 Mar 13.
9
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.国际基础和临床药理学联合会。CXII:腺苷受体:进一步更新。
Pharmacol Rev. 2022 Apr;74(2):340-372. doi: 10.1124/pharmrev.121.000445.
10
Assessment of biased agonism at the A adenosine receptor using β-arrestin and miniGα recruitment assays.使用β-arrestin 和 miniGα 招募测定评估 A 腺苷受体的偏激动作用。
Biochem Pharmacol. 2020 Jul;177:113934. doi: 10.1016/j.bcp.2020.113934. Epub 2020 Mar 26.
功能选择性和偏向性受体信号转导。
J Pharmacol Exp Ther. 2011 Feb;336(2):296-302. doi: 10.1124/jpet.110.173948. Epub 2010 Oct 28.
4
Functional selectivity in adrenergic and angiotensin signaling systems.肾上腺素能和血管紧张素信号系统的功能选择性。
Mol Pharmacol. 2010 Dec;78(6):983-92. doi: 10.1124/mol.110.067066. Epub 2010 Sep 20.
5
A3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells.A3 腺苷受体拮抗剂,截短的 Thio-Cl-IB-MECA,诱导 T24 人膀胱癌细胞凋亡。
Anticancer Res. 2010 Jul;30(7):2823-30.
6
Allosteric modulation of adenosine receptors.腺苷受体的变构调节
Biochim Biophys Acta. 2011 May;1808(5):1309-18. doi: 10.1016/j.bbamem.2010.06.013. Epub 2010 Jun 27.
7
Delineating the mode of action of adenosine A1 receptor allosteric modulators.阐明腺嘌呤 A1 受体变构调节剂的作用模式。
Mol Pharmacol. 2010 Sep;78(3):444-55. doi: 10.1124/mol.110.064568. Epub 2010 Jun 14.
8
Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.配体定向的 c-Jun N 端激酶激活破坏阿片受体信号转导。
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11608-13. doi: 10.1073/pnas.1000751107. Epub 2010 Jun 3.
9
The A2A adenosine receptor rescues neuritogenesis impaired by p53 blockage via KIF2A, a kinesin family member.A2A 腺苷受体通过驱动蛋白家族成员 KIF2A 拯救被 p53 阻断而受损的神经突生成。
Dev Neurobiol. 2010 Jul;70(8):604-21. doi: 10.1002/dneu.20802.
10
From cradle to twilight: the carboxyl terminus directs the fate of the A(2A)-adenosine receptor.从摇篮到暮年:羧基末端决定A(2A) - 腺苷受体的命运。
Biochim Biophys Acta. 2011 May;1808(5):1350-7. doi: 10.1016/j.bbamem.2010.05.009. Epub 2010 May 15.